Products for Research Use Only
RegisterLogin

Tafasitamab (Anti-CD19)

CAT: 0957-A2563-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0957-A2563-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Tafasitamab (Anti-CD19) is an Fc-modified, humanized monoclonal antibody that binds to the human B-cell surface antigen CD19. It is used in combination with allogeneic NK cell therapy in treatment of B-cell non-Hodgkin's lymphoma. MW:145.5 KD.
CAS Number
1422527-84-1
Synonyms
XmAb5574; MOR00208; Tafasitamab-cxix
Target
CD markers
Activity
Transmembrane Transporters
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Related Products

CatalogName
A00154-4Anti-Cd19 Antibody
A3160-1mg*5Loncastuximab (Anti-CD19)
A3120-1mg*5Obexelimab (Anti-CD19)
A2804-1mgColtuximab (Anti-CD19)
A2795-1mg*25Denintuzumab (Anti-CD19)
A2564-1mgInebilizumab (Anti-CD19)
A3160-1mg*25Loncastuximab (Anti-CD19)
A3120-1mg*25Obexelimab (Anti-CD19)
A3160-1mgLoncastuximab (Anti-CD19)
A3120-1mgObexelimab (Anti-CD19)

Alternative Products

CatalogName
C00354-1mgTafasitamab (Anti-CD19)
592225Tafasitamab (CD19)
F1074-.1Anti-CD19 Antibody (Tafasitamab)
047738CD19 (tafasitamab) discontinued
MBS1881744-01Anti-CD19 (tafasitamab biosimilar) mAb
MBS9246953-01Anti-CD19 Reference Antibody (tafasitamab)
BIO0002SM-20mgAnti-human CD19 (Tafasitamab Biosimilar)
BP21569401-01V9 Anti-Human CD19 (Tafasitamab)
B21569401-01V6 Anti-Human CD19 (Tafasitamab)
MBS1881745-01Biotinylated Anti-CD19 (tafasitamab biosimilar) mAb

Popular Products